Drug Development

Articles

The researchers will use 3D printing to design novel flow reactors and static mixers.

Almac Sciences Collaborates with Irish Manufacturing Research Organization on Flow Chemistry Reactors

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

SEDDS and SMEDDS improve solubility and permeability while expanding efficacy and applicability.

Lipids for Self-Emulsifying Drug Delivery Systems

Spectrum Chemical scientists give a shout-out to 10 chemicals impacting quality of life in conjunction with National Chemistry Week.

Spectrum Chemical Names Top 10 Chemicals Impacting Quality of Life

Advanced powder testing is a useful tool to differentiate materials and optimize the supply chain.

Building Robust Specifications Using Powder Testing

Meg Rivers is the former senior editor for 

Navigating a complex global regulatory landscape involves upfront research into the expectations of the different regulatory bodies, thorough documentation of every step of the API manufacturing process, and good communication. 

Global Regulatory Approach to API Manufacturing

Between dosage form versatility, product stability, lack of storage restrictions or need to refrigerate, and an easier means of purification, small-molecule APIs present an appealing market niche.

API Development and Manufacturing: Advantages of Working with Small Molecules

Drug makers are going beyond continuous improvement and green chemistry to increase the sustainability of small-molecule manufacturing.

Pharma Sets a Foundation for Greener API Manufacturing

David Lin, Ph. D., is with the Biologics Consulting Group.

Almost half of pharmaceutical industry profits continue to come from biopharmaceuticals.

Trends Affecting Biopharmaceutical Manufacturing

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

A new program will test the safety and suitability of new inactive ingredients to encourage the accelerated adoption of FDA-accepted excipients in drug development.

FDA Moves to Advance Innovative Excipients

AstraZeneca will establish an API manufacturing facility near Dublin, Ireland.

APIs and Excipients